pregnancy

Preliminary Study: Folic Acid Reduces Risk for Autism in Kids Prenatally Exposed to Antiepileptic Drugs

Several studies have observed that fetal exposure to the antiepileptic drug (AED), valproic acid (Depakote), may significantly increase the risk of having a child with an autism spectrum disorder.  In contrast, exposures to other AEDs, [...]

By |2025-06-26T09:07:59-04:00August 10th, 2016|Pregnancy & Medications|Comments Off on Preliminary Study: Folic Acid Reduces Risk for Autism in Kids Prenatally Exposed to Antiepileptic Drugs

When It Comes to Pregnancy, Bad Timing May Be a Risk Factor for Depression

In early studies designed to identify specific risk factors for postpartum depression, unplanned pregnancy was identified as a relatively weak predictor of postpartum depression.  But there are many different types of unplanned pregnancy. For example, [...]

By |2016-08-01T10:56:32-04:00July 31st, 2016|Depressive Disorders, Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on When It Comes to Pregnancy, Bad Timing May Be a Risk Factor for Depression

New Research from the CWMH: Evaluating the Risk of Major Malformations in Children Prenatally Exposed to Atypical Antipsychotics

Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data [...]

By |2016-07-12T15:30:24-04:00July 11th, 2016|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Research at CWMH, Risk of Malformations|Comments Off on New Research from the CWMH: Evaluating the Risk of Major Malformations in Children Prenatally Exposed to Atypical Antipsychotics

New Research from the CWMH: Evaluating the Risk of Major Malformations in Children Prenatally Exposed to Atypical Antipsychotics

Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data [...]

By |2021-03-29T10:51:11-04:00June 3rd, 2016|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Research at CWMH, Risk of Malformations|Comments Off on New Research from the CWMH: Evaluating the Risk of Major Malformations in Children Prenatally Exposed to Atypical Antipsychotics

CBT for Depression During Pregnancy: Good for Moms, Good for Babies

Australian researchers have developed a cognitive behavioural therapy (CBT) treatment intervention for antenatal depression and anxiety.  Beating the Blues Before Birth, to be delivered as individual therapy, was adapted from a 12-session group intervention for [...]

By |2016-03-14T14:45:49-04:00March 14th, 2016|Cannabis, Depressive Disorders, Perinatal Substance Use, Psychiatric Disorders During Pregnancy|Comments Off on CBT for Depression During Pregnancy: Good for Moms, Good for Babies

New Research from the CWMH: Newer Antipsychotics and Pregnancy

Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data [...]

By |2016-03-28T13:02:50-04:00March 10th, 2016|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Research at CWMH, Risk of Malformations|Comments Off on New Research from the CWMH: Newer Antipsychotics and Pregnancy
Go to Top